Tengion , Nasdaq: TNGN
Developing functional neo-organs using a patient's own cells.
Industry: Health Care
First Day Return: +0.4%
| IPO Data | |
|---|---|
| IPO Date | 04/08/2010 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $30 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | East Norriton, PA, United States |
| Founded | 2003 |
| Employees at IPO | 65 |
| Website www.tengion.com | |
Tengion (TNGN) Performance
